Improved efficacy of meglumine antimoniate incorporated in anionic liposomes against Leishmania infantum infecting canine macrophages.

Vanessa OrtegaAllan Radaic Marcelo Bispo B de Jesus Eneida de Paula Selma Giorgio

Published in: The Journal of pharmacy and pharmacology (2021)

Liposomal AME is a promising delivery system for treating visceral leishmaniasis, improving meglumine efficacy against L. infantum and minimizing its cytotoxicity towards canine macrophages.

Keyphrases

drug delivery
drug release
trypanosoma cruzi